Skip to main content

3D Cell Culture Market | Growth, Trends and Forecast 2018-2022

The major factors contributing to the growth of the 3D cell culture market include increasing incidences of cancer, growing awareness regarding the benefits of 3D cell culture, rising regulatory approvals for cell culture-based vaccines, funding for cell-based research, and technological advancements. On the other hand, high cost of cell biology research and lack of infrastructure for cell-based research in emerging economies are the major factors restraining the growth of this market. The high growth potential in the Asia-Pacific region provides growth opportunities to players in the 3D cell culture market.

3d cell culture market

This report aims to provide insights into the global 3D cell culture market. It provides valuable information on the technologies, applications, and end users in the 3D cell culture market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and Rest of the World (RoW). Growth in the North American segment is primarily driven by rising incidences of cancer, increasing government support in the form of grants and funding, expanding biopharmaceutical industry, and launch of new products in the market.

Download an Illustrative overview of the report:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847


Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the 3D cell culture market.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the 3D cell culture market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the 3D cell culture market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the 3D cell culture market
  • Market Development: Comprehensive information about emerging markets
The global 3D cell culture market size is expected to reach $1345.2 million by 2021 from $466.8 million in 2016, at a CAGR of 23.6%.

3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

Comments

Popular posts from this blog

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report  " In situ Hybridization Market  by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g

Interventional Oncology Market Latest Trends 2019

The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019. The market is expected to grow at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and the increasing government investments and funding for interventional oncology and related cancer research. The introduction of advanced interventional oncology products is a major technological advancement in the interventional oncology field. These advancements are largely related to the commercialization of more effective, simple, and easy-to-use products for interventional oncology procedures. Based on product, the interventional oncology market is segmented into ablation devices, embolization devices, an